SCHEMBL31184589

SCHEMBL31184589

C=Cc1ccc(C)c2c1NC(=O)N(C1CCC(C(=O)Nc3ccc(C)c(OC)c3)CC1)C2

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ CHKA P35790 1/20 0.38
▸ CHKB Q9Y259 1/20 0.38
▸ LMNA P02545 3/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 2/20 0.37
▸ ACHE P22303 1/20 0.37
▸ BACE1 P56817 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ TP53 P04637 2/20 0.36
▸ MALT1 Q9UDY8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31184485 0.92 POLB (0.41) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184841 0.90 POLB (0.45) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184359 0.89 POLB (0.47) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184652 0.88 POLB (0.39) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184756 0.88 POLB (0.43) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184531 0.87 POLB (0.40) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184644 0.87 MAPT (0.43) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184623 0.86 POLB (0.42) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184586 0.85 POLB (0.41) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4
SCHEMBL31184731 0.85 POLB (0.41) POLBSMN1; SMN2ALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024220626-A1 SMALL MOLECULE MODULATORS OF OGG1 AZKARRA THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
Send feedback